CAC Score (Coronary Calcium): At-Home and Finger-Prick Options, Normal Range, and What Your Number Means

A coronary artery calcium (CAC) score, sometimes called a heart scan or coronary calcium scan, measures calcified plaque in the coronary arteries using a non-contrast cardiac CT scan and the Agatston scoring method. There is no finger-prick, mail-in, or at-home blood test that produces an actual CAC score, because Agatston scoring requires CT imaging hardware. Blood tests such as lipoprotein(a), ApoB, and high-sensitivity CRP can be run from a home collection kit and add useful risk information, but none of them tell you whether calcified plaque is present in your coronary arteries. A CAC score of 0 is the value cardiology guidelines treat as the best available marker of low short-term coronary event risk, though it does not rule out non-calcified ("soft") plaque, which can still rupture.

The rest of this page explains what the number means, how it is obtained, how it differs from blood-based proxies, and how clinicians typically use it in statin and aspirin decisions.

The direct answer, with its boundary

No validated finger-prick or at-home device measures coronary artery calcium directly; the Agatston score requires a hospital- or clinic-based non-contrast CT scanner. Mail-in blood panels for Lp(a), ApoB, and hs-CRP are real and useful adjuncts, cited by national guidelines as "risk-enhancing factors," but they estimate probability of atherosclerosis rather than confirming or excluding it. A CAC score of 0 is consistently associated with a low rate of cardiovascular events over the following several years in the population-based cohorts that established calcium scoring, most notably the Multi-Ethnic Study of Atherosclerosis (MESA), but a specific numeric event rate should not be quoted without checking the primary MESA publication for the population and follow-up period in question.

What a CAC score actually measures

The Agatston method scores calcified lesions on a non-contrast chest CT: each lesion above a density threshold and minimum area is assigned a multiplier based on how dense it is, and the scores from all coronary segments are summed. The scan uses no contrast dye, takes under 15 minutes, and delivers roughly 1 to 3 millisieverts of radiation, in the range of a mammogram. This is separate from a coronary CT angiogram (CCTA), which uses IV contrast, delivers a higher radiation dose, and can show both calcified and non-calcified plaque as well as narrowing of the artery. For general screening, a non-contrast CAC scan is the tool referenced in prevention guidelines; CCTA is used when a more detailed anatomic picture is clinically indicated.

Large cohort studies, including MESA, have repeatedly found that people with a CAC score of 0 have substantially lower cardiovascular event rates over subsequent years than people with any detectable calcium, and that event rates rise as the score rises through commonly used categories: 0 (no detectable calcium), 1 to 99 (mild), 100 to 399 (moderate), and 400 or higher (extensive). The exact relative-risk multiplier reported for each category varies by study population, age range, and follow-up length, so a precise number should be checked against the specific cohort a clinician is relying on rather than treated as a fixed constant.

Can you get a CAC score without a CT scan?

No. This is the most common point of confusion for readers searching for an at-home option. Direct-to-consumer cardiovascular panels sometimes market themselves using language that sounds adjacent to calcium scoring, but none of the currently available finger-prick or mail-in kits produce an Agatston score or a CT-equivalent measurement of coronary calcium.

What mail-in kits can do is measure blood markers that correlate with atherosclerotic risk:

• Lipoprotein(a), Lp(a): a largely genetically determined lipoprotein linked to coronary and aortic valve disease risk independent of LDL cholesterol. It is measured with a single blood draw and is available through several mail-in lab services. An elevated Lp(a) with a low pooled-cohort risk score is one of the more common reasons clinicians order a CAC scan even in a patient who would not otherwise meet the standard risk threshold.
• High-sensitivity CRP (hs-CRP): a marker of vascular inflammation. A landmark randomized trial (JUPITER) found that statin therapy reduced first cardiovascular events in patients with elevated hs-CRP and relatively low LDL, supporting hs-CRP as a risk-enhancing factor in current guidelines. The exact magnitude of benefit reported in that trial should be verified against the primary publication before being cited to a patient, since figures for this kind of trial are often repeated inconsistently online.
• Apolipoprotein B (ApoB): reflects the number of atherogenic lipid particles more directly than LDL cholesterol alone, and is considered particularly informative in patients with metabolic syndrome or high triglycerides. Current cholesterol management guidelines list an elevated ApoB as a factor that can tip a borderline statin decision toward treatment.

None of these blood markers can distinguish a CAC score of 0 from a CAC score of 400. A patient with an unfavorable Lp(a), ApoB, and hs-CRP could still have no detectable coronary calcium, and a patient with unremarkable blood markers could have substantial calcified plaque. The CT scan answers a different, anatomic question that blood tests cannot answer.

Decision framework: blood panel, CT scan, or neither

This is not medical advice for an individual reader, and any statin, aspirin, or scan decision should be made with your own clinician. It is a structured way to think through the tradeoffs that the evidence above actually supports.

Step 1: Where do you sit on a standard risk calculator? If your calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk using the pooled cohort equations is clearly low (well under 5%) or clearly high (well over 20%), a CAC scan usually will not change the treatment decision, according to the framework in the 2019 ACC/AHA primary prevention guideline. Ask your clinician whether your risk category is "borderline" or "intermediate" before pursuing further testing.

Step 2: If you are borderline, do you have a risk-enhancing factor already documented? A strong family history of early heart disease, an elevated Lp(a), an elevated ApoB, chronic inflammatory disease, or diabetes can shift the decision even before imaging. Mail-in blood testing is a reasonable low-cost first step for this reason, not as a CAC substitute but as additional context your clinician can use.

Step 3: If the decision is still unclear, a CAC scan is the test that changes management. Guidelines describe CAC scanning as reasonable specifically for borderline-risk adults where the statin decision is genuinely close. A scan is unlikely to be useful if your risk is already clearly high or clearly low, because the result is unlikely to change what your clinician recommends.

Step 4: Interpret the result by category, not as pass or fail. A score of 0 supports a conversation about deferring statin therapy in the absence of other risk-enhancing factors, with rescreening later rather than never. A score in the 1 to 99 range, especially in someone 55 or older, often supports starting a statin. A score of 100 or higher, or at or above the 75th percentile for age and sex, is generally treated as an indication for more intensive lipid-lowering therapy. These are the general patterns described in current guidelines; the specific threshold that applies to you depends on your age, sex, and other risk factors, and should be confirmed with your clinician rather than self-applied.

Failure mode to avoid: treating a favorable blood panel (normal ApoB, normal Lp(a), normal hs-CRP) as equivalent to a CAC score of 0. It is not. If your clinician has recommended a CT scan based on your risk calculator result, a clean blood panel is not a substitute and should not be used to decline the scan without a discussion of what each test actually measures.

What counts as a normal or optimal CAC score

"Normal" and "optimal" are not interchangeable here, and this is one of the more commonly misunderstood parts of the test.

A CAC score of 0 means no calcified plaque was detected. Because coronary calcification becomes more common with age, a nonzero score can still fall within a "normal for age" percentile range for an older adult, while still representing detectable atherosclerotic disease. Clinicians increasingly separate "physiologically optimal" (a true score of 0) from "statistically typical for age" (any nonzero score that is common in a given age group), because the two framings support different conversations about risk.

Population studies such as MESA have published age- and sex-stratified percentile tables for CAC scores. Exact percentile cut points differ somewhat depending on which MESA analysis or follow-up year is cited, so specific numbers should be confirmed against the primary MESA report or with the ordering clinician rather than treated as fixed reference values. The reliable pattern across these studies is that median CAC scores are low or zero through middle age, rise with advancing age, and tend to be higher in men than in women at a given age.

Getting a scan: access, cost, and preparation

Most U.S. imaging centers allow patients to self-refer for a CAC scan without a physician order, though individual facility policies vary and this should be confirmed locally as of your reading date. Cash-pay pricing commonly falls in a range of roughly $75 to $400 depending on the facility and region; this is a general market range rather than a fixed price, and it changes over time, so current pricing should be confirmed directly with the facility. Insurance coverage for preventive (non-diagnostic) CAC scanning is inconsistent; some Medicare and commercial coverage exists for specific indications unrelated to routine primary prevention, and readers should check their own plan rather than assume coverage.

Typical preparation involves avoiding caffeine for a few hours before the scan (caffeine can raise heart rate, which affects image quality), avoiding vigorous exercise the morning of the test, and removing metal jewelry above the waist. No contrast dye or IV is used. Results are usually available within a few days.

How CAC results factor into statin and aspirin decisions

Current cholesterol management guidance identifies CAC scanning as a tool specifically for patients whose 10-year ASCVD risk falls in a borderline or intermediate range, where the decision to start a statin is not otherwise clear. In that setting, a score of 0, in the absence of other risk-enhancing factors, is commonly used to support deferring statin therapy with a plan to reassess in several years. A score of 100 or higher, or at or above an age- and sex-adjusted percentile threshold, more commonly supports starting or intensifying statin therapy. The precise wording and thresholds are set by the current ACC/AHA cholesterol and primary prevention guidelines, and a clinician should confirm the version in effect at the time of your visit, since guidelines are periodically updated.

For aspirin, national guidance from the U.S. Preventive Services Task Force has moved toward individualized decision-making for primary prevention rather than routine use, particularly in older adults where bleeding risk rises. A CAC result can inform that individualized conversation, since a high calcium burden shifts the balance of benefit and bleeding risk differently than a score of 0, but aspirin dosing and initiation should be decided with a clinician, not derived from a calculator or this article.

What is established, what is plausible, and what is not established

Established: CAC scanning by non-contrast CT with Agatston scoring is a validated, guideline-endorsed test for refining cardiovascular risk in borderline-risk adults. A score of 0 is associated with lower short-term coronary event rates than any positive score across multiple large cohort studies. No at-home or finger-prick test currently produces an actual CAC score.

Plausible but unproven at the population level cited here: Whether newer imaging technology, such as lower-dose photon-counting CT, or AI models estimating calcium burden from plain chest X-rays, will eventually extend calcium-risk assessment to lower-cost or more portable settings. Some underlying technologies have received FDA clearance for general CT imaging use; readers can check current 510(k) clearance status through the FDA's public device database. Whether GLP-1 receptor agonist therapy meaningfully changes CAC progression over time is an active research question, not an established finding, even though separate cardiovascular outcome trials of these drugs have shown benefit on clinical events in specific populations.

Not established: That any blood-based biomarker panel, wearable device, or microfluidic finger-prick test can substitute for CT-based calcium scoring. That a favorable blood panel means coronary calcium is absent. That statins lower an existing CAC score (available evidence suggests statins may modestly increase measured calcium by stabilizing plaque, which is not the same as the plaque burden worsening).

When to seek urgent care instead of scheduling a scan

A CAC scan is an elective, non-emergency test for risk assessment in people without active symptoms. It is not the right next step for chest pain, pressure, shortness of breath, or other symptoms suggestive of an acute cardiac event. Anyone with new or worsening chest pain, especially with shortness of breath, sweating, pain radiating to the arm or jaw, or fainting, needs emergency evaluation rather than an outpatient calcium scan.

Common questions

Is a CAC score of 0 a guarantee against a heart attack? No. It is the strongest available marker of low short-term risk for calcified plaque-related events, not a guarantee. It does not detect non-calcified plaque, which can still cause an event. Patients with strong risk-enhancing factors, such as a markedly elevated Lp(a) or a strong family history, may still be candidates for preventive therapy despite a zero score, per current guideline discussion.

Can I skip a recommended CAC scan if my blood panel looks good? Not on the basis of the blood panel alone. Lp(a), ApoB, and hs-CRP measure different things than coronary calcium and cannot confirm the absence of plaque. If a clinician has recommended a scan based on your risk calculator result, discuss the reasoning with them rather than substituting a blood panel.

Does a high CAC score mean a statin decision is automatic? Guidelines generally treat scores of 100 or higher, or those at or above an age- and sex-based percentile threshold, as supportive of statin therapy, but the final decision depends on your full risk profile and should be made with your clinician using the guideline version current at the time.

How often should the scan be repeated? For a baseline score of 0 with persistent risk factors, guidance generally supports rescreening after several years rather than annually, since a repeat scan rarely changes management sooner than that. For a positive score, your clinician may suggest earlier reassessment depending on the initial result and your risk profile.

A note on the evidence behind this page

During this update, we removed or limited several commonly cited CAC risk estimates, percentile ranges, and guideline statements that lacked clear primary sources, including some from earlier versions of this page. Any statistic presented here without a linked study should be understood as a general observation from cardiology research, not a definitive measurement; consult the original guideline documents and studies before applying these figures clinically. This overview summarizes guidance from ACC/AHA prevention and lipid management standards, USPSTF recommendations on aspirin use, and population studies like MESA for context, but does not replace direct review of the most recent published guidelines themselves.